PIRFETAB 200MG

About

Pirfetab 200mg contains Pirfenidone, an antifibrotic agent used in the treatment of idiopathic pulmonary fibrosis (IPF). IPF is a chronic, progressive lung disease characterized by the scarring (fibrosis) of lung tissue, leading to a decline in lung function. Pirfenidone works by inhibiting the synthesis of various pro-fibrotic cytokines and growth factors, such as TGF-beta and TNF-alpha, and reducing fibroblast proliferation. This action helps to slow the progression of fibrosis, preserve lung function, and improve survival in patients with mild to moderate IPF.

It is a targeted therapy that aims to modify the disease course rather than just manage symptoms. Regular monitoring of lung function and potential side effects, particularly liver function, is crucial during treatment to ensure patient safety and optimize therapeutic outcomes.

Uses

• Treatment of idiopathic pulmonary fibrosis (IPF).
• Slowing the progression of lung fibrosis.
• Preserving lung function in IPF patients.
• Improving survival in mild to moderate IPF.

Directions For Use

Take orally with food, as directed by your physician, usually three times daily.

Benefits

• Slows progression of IPF.
• Preserves lung function.
• Improves survival rates in IPF.
• Reduces fibrotic activity in lungs.
• Targeted therapy for IPF.
• Can improve quality of life.

Side Effects

• Nausea
• Diarrhea
• Abdominal pain
• Indigestion
• Fatigue
• Headache
• Dizziness
• Photosensitivity (sunburn risk)
• Rash
• Liver enzyme elevation
• Anorexia
• Weight loss

Safety Measures

• Alcohol - Avoid or limit alcohol as it can increase the risk of liver side effects.
• Pregnancy - Not recommended during pregnancy due to insufficient safety data; use only if clearly necessary.
• Breastfeeding - Avoid during breastfeeding as it may pass into breast milk and potential effects on infant are unknown.
• Liver - Contraindicated in severe liver impairment; monitor liver function tests regularly during treatment.
• Kidney - Use with caution in patients with severe renal impairment; dose adjustment may be necessary.
• Lung - Specifically used for lung conditions (IPF); generally safe for other non-IPF lung conditions, but consult specialist.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.